Cannabix Delivers Marijuana Breath Test to Canadian Workplace Testing Clinic

Event summary

  • Cannabix Technologies delivered its Marijuana Breath Test (MBT) to a workplace drug and alcohol testing clinic in eastern Canada on May 4, 2026.
  • The clinic serves commercial companies, private businesses, government agencies, and individual clients.
  • The delivery was completed through an authorized reseller.
  • The MBT offers a non-invasive, breath-based THC testing solution aligned with recent cannabis use.

The big picture

Cannabix's delivery of the MBT to a workplace testing clinic highlights the growing demand for more relevant, timely, and defensible tools to assess recent cannabis use. Traditional urine and oral fluid tests face challenges due to their inability to correlate with recent use, creating operational and legal risks. Breath-based THC testing offers a non-invasive, objective solution that aligns with real-world workplace safety decision-making.

What we're watching

Market Adoption
The pace at which workplace drug testing clinics adopt breath-based THC testing technology.
Regulatory Compliance
Whether the MBT can reduce legal challenges associated with historical cannabis use positives.
Competitive Positioning
How Cannabix's MBT differentiates itself in the workplace safety and compliance market.

Related topics

Technology